Trial Profile
Randomized, Open-label Crossover Study to Evaluate Comparative Pharmacokinetics of Vitamin D3 Between DP-R206(150mg Ibandronate / 24,000 IU Vitamin D3 tablet) and a 24,000 IU Vitamin D3 in healthy adult volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Colecalciferol (Primary) ; Colecalciferol/ibandronic-acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacokinetics
- Acronyms DP-R206
- Sponsors Alvogen; DreamPharma Corporation
- 31 Oct 2016 Status changed from recruiting to completed.
- 14 Feb 2013 New trial record